Literature DB >> 18611637

Home intravenous antibiotic therapy (HIVAT): indications, patients and antimicrobial agents.

D N Williams1.   

Abstract

Concern regarding escalating costs of inhospital intravenous (i.v.) antibiotic treatment has stimulated interest in providing i.v. antibiotic therapy in outpatient or home settings (HIVAT). HIVAT should be considered when patients no longer need careful observation and daily nursing care. Successful HIVAT can be accomplished utilizing a team approach emphasizing the respective roles of the physician, pharmacist, nurse and patient. This paper is based on a retrospective review of approximately 1500 patients (19 500 days of HIVAT), treated between 1978 and 1993, in a hospital-based programme. This review addresses which infectious diseases can be treated with HIVAT, with special emphasis on patient and antibiotic selection criteria and the importance of patient monitoring and preliminary data on the outcomes of such therapy.

Entities:  

Year:  1995        PMID: 18611637     DOI: 10.1016/0924-8579(94)00046-w

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

2.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

3.  Evolution of Antibiotic Use and Cost in Patients with Community-Acquired Pneumonia.

Authors:  Sergio Sabbatani; Raffaella Cesari; Emanuela Pipitone
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

Review 4.  Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.

Authors:  S Esposito
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 5.  Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.

Authors:  D Nathwani
Journal:  Drugs       Date:  2000       Impact factor: 9.546

6.  Meropenem. A pharmacoeconomic review of its use in serious infections.

Authors:  S M Holliday; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981

Review 7.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

Review 8.  Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit.

Authors:  Sara Ortonobes; Abel Mujal-Martínez; María de Castro Julve; Alba González-Sánchez; Rafael Jiménez-Pérez; Manuel Hernández-Ávila; Natalia De Alfonso; Ingrid Maye-Pérez; Teresa Valle-Delmás; Alba Rodríguez-Sánchez; Jessica Pino-García; Mònica Gómez-Valent
Journal:  Antibiotics (Basel)       Date:  2022-08-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.